CDK 4/6 Inhibitors: New Choices for HR-Positive, HER2-Negative Metastatic Breast Cancer |
- 1.00 AMA PRA Category 1 Credit™ credit
- 1.00 ANCC credit
- 1.00 Attendance credit
|
Enduring |
|
09/13/2016 to 05/02/2018 |
Triggering the Immune System: Immune Checkpoint Inhibitors for the Treatment of Non–Small Cell Lung Cancer |
- 1.00 AMA PRA Category 1 Credit™ credit
- 1.00 ACPE credit
- 1.00 ANCC credit
- 1.00 Attendance credit
|
Enduring |
|
12/21/2016 to 05/09/2018 |
Current and Future Directions in the Treatment of Colorectal Cancer |
- 1.00 AMA PRA Category 1 Credit™ credit
- 1.00 ACPE credit
- 1.00 ANCC credit
- 1.00 Attendance credit
|
Enduring |
|
02/21/2017 to 06/20/2018 |
Current and Future Directions in the Treatment of Pulmonary Neuroendocrine Tumors |
- 1.00 AMA PRA Category 1 Credit™ credit
- 1.00 ANCC credit
- 1.00 Attendance credit
|
Enduring |
|
01/18/2017 to 05/04/2018 |
Staying Up to Date on the Treatment of Advanced HR-Positive, HER2-Negative Breast Cancer |
- 1.00 AMA PRA Category 1 Credit™ credit
- 1.00 ACPE credit
- 1.00 ANCC credit
- 1.00 Attendance credit
|
Enduring |
|
05/03/2017 to 05/02/2018 |
The Latest Advances in CAR T-Cell Therapy for Refractory and Relapsed Lymphomas and Leukemias |
- 1.00 AMA PRA Category 1 Credit™ credit
- 1.00 ANCC credit
- 1.00 Attendance credit
|
Enduring |
|
09/12/2017 to 09/11/2018 |
Autologous Hematopoietic Stem Cell Transplantation and Mobilization in Multiple Myeloma: Current Debate and Developments |
- 1.00 AMA PRA Category 1 Credit™ credit
- 1.00 ACPE credit
- 1.00 ANCC credit
- 1.00 Attendance credit
|
Enduring |
|
10/02/2017 to 10/01/2018 |
Chemotherapeutic Strategies for Advanced NSCLC in the Era of Personalized Medicine: A Focus on Platinum-Refractory Disease |
- 1.00 AMA PRA Category 1 Credit™ credit
- 1.00 ANCC credit
- 1.00 Attendance credit
|
Enduring |
|
08/14/2017 to 12/28/2018 |
Hemophilia: Triumphs, Challenges, and Shared Decision Making in the Management of Hemophilia A (Specialty Centers) |
- 1.00 AMA PRA Category 1 Credit™ credit
- 1.00 ANCC credit
- 1.00 Attendance credit
|
Enduring |
|
10/02/2017 to 10/01/2018 |
Hemophilia: Triumphs, Challenges, and Shared Decision Making in the Management of Hemophilia B (Community Centers) |
- 1.00 AMA PRA Category 1 Credit™ credit
- 1.00 ANCC credit
- 1.00 Attendance credit
|
Enduring |
|
10/02/2017 to 10/01/2018 |